HK1075659A1 - A process for producing phenserine and its analog - Google Patents
A process for producing phenserine and its analogInfo
- Publication number
- HK1075659A1 HK1075659A1 HK05107730A HK05107730A HK1075659A1 HK 1075659 A1 HK1075659 A1 HK 1075659A1 HK 05107730 A HK05107730 A HK 05107730A HK 05107730 A HK05107730 A HK 05107730A HK 1075659 A1 HK1075659 A1 HK 1075659A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- phenserine
- analog
- producing
- compounds
- isocyanate
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/042,586 US6495700B1 (en) | 2002-01-09 | 2002-01-09 | Process for producing phenserine and its analog |
PCT/US2002/039537 WO2003059909A1 (en) | 2002-01-09 | 2002-12-11 | A process for producing phenserine and its analog |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1075659A1 true HK1075659A1 (en) | 2005-12-23 |
Family
ID=21922704
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK05107730A HK1075659A1 (en) | 2002-01-09 | 2005-09-02 | A process for producing phenserine and its analog |
Country Status (16)
Country | Link |
---|---|
US (1) | US6495700B1 (zh) |
EP (1) | EP1463729B1 (zh) |
JP (1) | JP2005514459A (zh) |
KR (2) | KR20060097772A (zh) |
CN (1) | CN1301995C (zh) |
AT (1) | ATE466015T1 (zh) |
AU (1) | AU2002353102B2 (zh) |
BR (1) | BRPI0215492A2 (zh) |
CA (1) | CA2470560C (zh) |
DE (1) | DE60236207D1 (zh) |
HK (1) | HK1075659A1 (zh) |
HR (1) | HRP20040606A2 (zh) |
HU (1) | HUP0500747A3 (zh) |
IL (1) | IL162827A0 (zh) |
PL (1) | PL374240A1 (zh) |
WO (1) | WO2003059909A1 (zh) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7897639B2 (en) | 2003-10-21 | 2011-03-01 | Colucid Pharmaceuticals, Inc. | Carbamoyl esters that inhibit cholinesterase and release pharmacologically active agents |
WO2006138385A2 (en) * | 2005-06-14 | 2006-12-28 | Cancog Technologies Inc.24 | Use of phenserine and analogs to treat behavioral problems and improve trainability |
EP2275095A3 (en) | 2005-08-26 | 2011-08-17 | Braincells, Inc. | Neurogenesis by muscarinic receptor modulation |
EP2258359A3 (en) | 2005-08-26 | 2011-04-06 | Braincells, Inc. | Neurogenesis by muscarinic receptor modulation with sabcomelin |
AU2007292848A1 (en) * | 2006-09-08 | 2008-03-13 | Braincells, Inc. | Combinations containing a 4-acylaminopyridine derivative |
CA2789014C (en) | 2010-02-09 | 2019-01-15 | Michela Gallagher | Methods and compositions for improving cognitive function |
US20120225922A1 (en) | 2011-03-04 | 2012-09-06 | Qr Pharma | Effective Amounts of (3aR)-1,3a,8-Trimethyl-1,2,3,3a,8,8a-hexahydropyrrolo [2,3-b]indol-5-yl Phenylcarbamate and Methods of Treating or Preventing Neurodegeneration |
US20130096316A1 (en) * | 2011-10-14 | 2013-04-18 | Qr Pharma, Inc. | Novel Method for Preparation of Bisnorcymerine and Salts Thereof |
WO2014078568A1 (en) | 2012-11-14 | 2014-05-22 | The Johns Hopkins University | Methods and compositions for treating schizophrenia |
EP3827820A1 (en) | 2013-03-15 | 2021-06-02 | The Johns Hopkins University | Brivaracetam for improving cognitive function |
US11160785B2 (en) | 2013-03-15 | 2021-11-02 | Agenebio Inc. | Methods and compositions for improving cognitive function |
BR112017025031B1 (pt) | 2015-05-22 | 2023-03-21 | Agenebio, Inc | Composições farmacêuticas de liberação prolongada de levetiracetam |
AU2016309815B2 (en) | 2015-08-14 | 2022-04-07 | Annovis Bio, Inc. | Methods of treatment or prevention of acute brain or nerve injuries |
EP3654957A4 (en) | 2017-05-24 | 2021-06-23 | Annovis Bio, Inc. | PREVENTION OR TREATMENT OF DISEASE CONDITIONS DUE TO METAL DIS-HOMEOSTASIS BY ADMINISTERING POSIPHES TO HEALTHY OR SICK PEOPLE |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1109003B (it) * | 1977-09-20 | 1985-12-16 | Univ Firenze | Derivati dell 1 2 3 8 3 a 8 a esai dropirrolo 23 b indolo |
US5306825A (en) | 1984-03-01 | 1994-04-26 | Consiglio Nazionale Delle Ricerche | Physostigmine derivatives with acetylcholinesterase inhibition properties, and the relative production process |
IT1199076B (it) * | 1984-03-01 | 1988-12-30 | Consiglio Nazionale Ricerche | Derivati della fisostigmina con proprieta'di inibizione della aceticolinesterasi e relativo procedimento di produzione |
US4791107A (en) | 1986-07-16 | 1988-12-13 | Hoechst-Roussel Pharmaceuticals, Inc. | Memory enhancing and analgesic 1,2,3,3A,8,8A-hexahydro-3A,8 (and) 1,3A,8)-di(and tri)methylpyrrolo(2,3-B)indoles, compositions and use |
IT1225462B (it) * | 1987-04-03 | 1990-11-14 | Mediolanum Farmaceutici Srl | Sali organici di derivati della fisostigmina |
US5187165A (en) | 1987-05-15 | 1993-02-16 | Hoechst-Roussel Pharmaceuticals Inc. | Memory enhancing and analgesic 1,2,3a,8,8a-hexahydro-3a,8(and 1,3a,8)-di(and tri)methylpyrrolo[2,3-b]indoles |
US4900748A (en) | 1988-03-04 | 1990-02-13 | The United States Of America As Represented By The Department Of Health And Human Services | Carbamates related to (-)-physostigmine as cholinergic agents |
US5260452A (en) | 1989-11-03 | 1993-11-09 | Hoechst-Roussel Pharmaceuticals Inc. | 4- and 6-carbamates related to physostigmine and intermediates for the preparation thereof |
US5077289A (en) | 1989-11-30 | 1991-12-31 | Hoechst Roussel Pharmaceuticals Inc. | Memory enhancing and analgesic aminocarbonylcarbamates related to physostigmine |
US5177101A (en) | 1989-11-30 | 1993-01-05 | Hoechst-Roussel Pharmaceuticals Incorporated | Memory enhancing and analgesic aminocarbonylcarbamates related to physostigmine |
US5705657A (en) | 1991-02-14 | 1998-01-06 | Labochim Laboratorio Chimico Internazionale S.P.A. | Isocyanate process for the preparation of 1,3A,8-trimethyl-1,2,3,3A, 8, 8A-hexahydro-pyrrole 2,3-B! indol-5 (3AS, 8AR) -hepthylcarbamate |
EP0499959A1 (en) | 1991-02-18 | 1992-08-26 | Bromine Compounds Ltd. | Process for the manufacture of substituted maleimides |
EP0606366B1 (en) | 1991-09-26 | 2003-06-04 | THE GOVERNMENT OF THE UNITED STATES OF AMERICA as represented by THE SECRETARY of the DEPARTMENT OF HEALTH AND HUMAN SERVICES | Substituted phenserines and phenylcarbamates of (-)-eseroline, (-)-n1-noreseroline, and (-)-n1-benzylnoreseroline; as specific inhibitors of acetylcholinesterase |
US5206260A (en) | 1991-11-07 | 1993-04-27 | Merck & Co., Inc. | Hexahydropyrrolo[2,3-b]indole derivatives |
FI933264A (fi) * | 1992-07-21 | 1994-01-22 | Hoechst Roussel Pharma | Foerfarande foer framstaellning av fysostigminkarbamatderivat fraon fysostigmin |
US5302721A (en) | 1992-07-21 | 1994-04-12 | Hoechst-Roussel Pharmaceuticals Incorporated | Method of preparation of physostigmine carbamate derivatives from eseretholes |
US5409948A (en) | 1992-11-23 | 1995-04-25 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Method for treating cognitive disorders with phenserine |
US5665880A (en) | 1996-10-31 | 1997-09-09 | Hoechst Marion Roussel, Inc. | Method of preparation of physostigmine carbamate derivatives from eseretholes |
US5677457A (en) | 1996-12-19 | 1997-10-14 | Hoechst Marion Roussel, Inc. | Method of preparation of physostigmine carbamate derivatives from eseroline ethers |
-
2002
- 2002-01-09 US US10/042,586 patent/US6495700B1/en not_active Expired - Lifetime
- 2002-12-11 BR BRPI0215492A patent/BRPI0215492A2/pt not_active IP Right Cessation
- 2002-12-11 HU HU0500747A patent/HUP0500747A3/hu unknown
- 2002-12-11 CN CNB028269985A patent/CN1301995C/zh not_active Expired - Fee Related
- 2002-12-11 KR KR1020067017072A patent/KR20060097772A/ko not_active Application Discontinuation
- 2002-12-11 IL IL16282702A patent/IL162827A0/xx unknown
- 2002-12-11 PL PL02374240A patent/PL374240A1/xx unknown
- 2002-12-11 WO PCT/US2002/039537 patent/WO2003059909A1/en active IP Right Grant
- 2002-12-11 AU AU2002353102A patent/AU2002353102B2/en not_active Ceased
- 2002-12-11 AT AT02790077T patent/ATE466015T1/de active
- 2002-12-11 EP EP02790077A patent/EP1463729B1/en not_active Expired - Lifetime
- 2002-12-11 CA CA002470560A patent/CA2470560C/en not_active Expired - Fee Related
- 2002-12-11 DE DE60236207T patent/DE60236207D1/de not_active Expired - Lifetime
- 2002-12-11 KR KR1020047010683A patent/KR100712003B1/ko active IP Right Grant
- 2002-12-11 JP JP2003560012A patent/JP2005514459A/ja active Pending
-
2004
- 2004-07-02 HR HRP20040606 patent/HRP20040606A2/hr not_active Application Discontinuation
-
2005
- 2005-09-02 HK HK05107730A patent/HK1075659A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
EP1463729A4 (en) | 2005-06-29 |
PL374240A1 (en) | 2005-10-03 |
EP1463729B1 (en) | 2010-04-28 |
HRP20040606A2 (en) | 2004-12-31 |
KR20040072711A (ko) | 2004-08-18 |
HUP0500747A2 (hu) | 2005-11-28 |
DE60236207D1 (de) | 2010-06-10 |
CN1301995C (zh) | 2007-02-28 |
IL162827A0 (en) | 2005-11-20 |
CA2470560A1 (en) | 2003-07-24 |
JP2005514459A (ja) | 2005-05-19 |
CN1612880A (zh) | 2005-05-04 |
CA2470560C (en) | 2007-05-15 |
BRPI0215492A2 (pt) | 2016-07-05 |
US6495700B1 (en) | 2002-12-17 |
KR20060097772A (ko) | 2006-09-15 |
HUP0500747A3 (en) | 2009-05-28 |
EP1463729A1 (en) | 2004-10-06 |
KR100712003B1 (ko) | 2007-05-02 |
AU2002353102B2 (en) | 2007-05-24 |
ATE466015T1 (de) | 2010-05-15 |
WO2003059909A1 (en) | 2003-07-24 |
AU2002353102A1 (en) | 2003-07-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1075659A1 (en) | A process for producing phenserine and its analog | |
RS59404A (en) | Method for producing scopine esters | |
IL174469A0 (en) | Rearranged pentanols, a method for the production thereof, and their use as antiphlogistics | |
TNSN05105A1 (en) | Novel bicyclic inhibitors of hormone sensitive lipase | |
HK1106518A1 (en) | Improved method for preparing 3-hydroxy-4-hydroxymethyl-pyrrolidine compounds | |
IL175253A0 (en) | A process for preparing pyrrole derivatives | |
GB0222056D0 (en) | Process for the manufacture of organic compounds | |
MXPA04007396A (es) | Proceso para la elaboracion de inhibidores de reductasa hmg-coa. | |
MXPA05008183A (es) | Proceso para preparar pirrolotriazina como inhibidores de cinasa. | |
IL162817A0 (en) | Process for the manufacture of organic compounds | |
WO2004043918A3 (en) | Novel crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms | |
GB0204129D0 (en) | Process for the manufacture of organic compounds | |
MY145842A (en) | Method of producing triethanolamine | |
TW200626606A (en) | Process for preparing phosphorus compounds having phosphate-phosphonate bond | |
UA85428C2 (ru) | Способ получения с-2, с-3 замещенных n-алкилированных индолов, а также промежуточные соединения и способы их получения | |
TW200942546A (en) | A crystalline form of (R)-6-cyclopentyl-6-(2-(2,6-diethylpyridin-4-yl)ethyl)-3-((5,7-dimethyl-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl)methyl)-4-hydroxy-5,6-dihydropyran-2-one | |
GB0210234D0 (en) | Process for the manufacture of organic compounds | |
AU2003267565A8 (en) | Process for the production of a fuel composition | |
WO2006043175A3 (en) | Process for preparing purine compounds | |
TW200624435A (en) | Process for preparing iridium(Ⅲ) ketoketonates | |
GB0010475D0 (en) | Organic compounds | |
IL146811A0 (en) | Novel method for preparing benzoperhydroisoindole compounds | |
WO2007096903A3 (en) | New crystalline form of atorvastatin hemi-calcium | |
GB2425309A (en) | C2-fluoro pyrrolo[2,1-c][1,4]benzodiazepine dimers | |
GB0320738D0 (en) | Novel process |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20101211 |